Grand River Aseptic Manufacturing Grows Team to Serve New Facility, Announces Addition to Business Development
Grand River Aseptic Manufacturing (“GRAM”), a leading parenteral contract development and manufacturing organization, announced the addition of industry expert Mary Lou Glotzbach to the GRAM team. Mary Lou joins GRAM as Sr. Business Development Manager serving the Mid-Atlantic.
“GRAM is going through an exciting time with the addition of their new facility and rapid growth over the past few years. Joining the team during this growth is a tremendous opportunity,” said Mary Lou. “Quality and customer service are at the core of the GRAM business model and I am honored to be a part it. I look forward to sharing how GRAM’s capabilities, modern equipment, and company culture stands out in the industry.”
Prior to joining GRAM, Mary Lou excelled in management roles at Pfizer Centre One, Hospira, and Abbott Laboratories. She is highly skilled in establishing relationships, accurately defining company’s needs, and driving opportunities to closure. Mary Lou’s impressive ability to guide support functions through due diligence and risk assessment processes ensures customers and their product receive the ultimate level of service.
“We are excited to welcome Mary Lou to our team. Mary Lou is one of the top business development professionals in the CDMO industry, and her energy and passion will be invaluable as GRAM opens its new state-of-the-art manufacturing facility. Her experience and deep industry expertise are vital as we continue to grow,” said Dave Powell, Vice President Business Development. “Having worked with Mary Lou for many years during her career, I look forward to working with her again and seeing all she will accomplish in driving our business development efforts.”
GRAM produces parenteral therapeutics to various clients from clinical trials to commercialization. Inc. 5000’s three-time recognition of GRAM is testament to its dedication to growth that provides opportunities to improve the lives of people around the world through parenteral drugs. Opening soon, GRAM’s large-scale fill/finish facility expansion will enable the manufacturer to continue delivering high quality solutions in a world class facility for customers with biologic and small molecule projects. The new facility will be GRAM’s fifth location in Grand Rapids.
About Grand River Aseptic Manufacturing, Inc.
Grand River Aseptic Manufacturing, Inc. (“GRAM”), a parenteral contract development and manufacturing organization, delivers customized solutions to meet clients’ fill and finish needs from development through commercialization. With capabilities for biologics as well as controlled substances, GRAM’s expert project managers and modern facilities support pharmaceutical development and cGMP manufacturing, analytical testing and regulatory filing.